ADMA Biologics (ADMA) Insider Trading & Ownership $17.26 +0.01 (+0.03%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$12.90M Get ADMA Insider Trade Alerts Want to know when executives and insiders are buying or selling ADMA Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADMA Insider Buying and Selling by Quarter ADMA Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2025Steve ElmsDirectorSell194,749$20.24$3,941,719.76 6/13/2025Steve ElmsDirectorSell137,931$20.82$2,871,723.42 6/12/2025Steve ElmsDirectorSell92,941$21.69$2,015,890.29 6/9/2025Jerrold B GrossmanDirectorSell10,000$21.31$213,100.00 6/9/2025Lawrence P GuiheenDirectorSell20,000$20.96$419,200.00 5/22/2025Lawrence P GuiheenDirectorSell1,221$20.12$24,566.52 5/21/2025Lawrence P GuiheenDirectorSell7,779$20.32$158,069.28 11/22/2024Brad L TadeCFOSell15,000$21.15$317,250.00 9/9/2024Lawrence P GuiheenDirectorSell9,000$18.47$166,230.00 8/30/2024Kaitlin M Kestenberg-MessinaCOOSell24,150$16.90$408,135.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/29/2024Jerrold B GrossmanDirectorSell136,861$17.27$2,363,589.47 (Data available from 1/1/2013 forward) ADMA Insider Trading Activity - Frequently Asked Questions Who is on ADMA Biologics' Insider Roster? The list of insiders at ADMA Biologics includes Adam S Grossman, Brad L Tade, Brian Lenz, Bryant Fong, Jerrold B Grossman, Kaitlin M Kestenberg-Messina, Lawrence P Guiheen, Steve Elms, and Young Kwon. Learn more on insiders at ADMA. What percentage of ADMA Biologics stock is owned by insiders? 3.50% of ADMA Biologics stock is owned by insiders. Learn more on ADMA's insider holdings. Which ADMA Biologics insiders have been buying company stock? The following insider purchased ADMA shares in the last 24 months: Jerrold B Grossman ($482,300.00). How much insider buying is happening at ADMA Biologics? Insiders have purchased a total of 130,000 ADMA shares in the last 24 months for a total of $482,300.00 bought. Which ADMA Biologics insiders have been selling company stock? The following insiders have sold ADMA shares in the last 24 months: Adam S Grossman ($5,262,566.41), Brad L Tade ($317,250.00), Jerrold B Grossman ($2,576,689.47), Kaitlin M Kestenberg-Messina ($408,135.00), Lawrence P Guiheen ($768,065.80), Steve Elms ($12,756,502.42), and Young Kwon ($1,095,600.00). How much insider selling is happening at ADMA Biologics? Insiders have sold a total of 1,686,416 ADMA Biologics shares in the last 24 months for a total of $23,184,809.10 sold. ADMA Biologics Key ExecutivesMr. Adam S. Grossman (Age 47)Co-Founder, President, CEO & Director Compensation: $1.59MDr. Jerrold B. Grossman D.P.S. (Age 76)Ph.D., Co-Founder & Vice Chairman of the Board Compensation: $90kMs. Kaitlin Kestenberg (Age 37)COO & Senior VP of Compliance Mr. Drew PantelloVice President of Marketing & Corporate DevelopmentMs. Cindy PetersenExecutive Director of Human ResourcesMr. Skyler BloomSenior Director of Business Development & Corporate StrategyMr. Brad TadeVice President of Financial Operations More Insider Trading Tools from MarketBeat Related Companies ACAD Insider Selling AKRO Insider Selling ALLO Insider Selling FGEN Insider Selling GMAB Insider Selling VTRS Insider Selling MRNA Insider Selling BBIO Insider Selling VRNA Insider Selling ELAN Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:ADMA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access